Diaverum, a leading global provider of renal care services, is headquartered in Sweden (SE) and operates extensively across Europe, Latin America, and the Middle East. Founded in 1991, the company has established itself as a key player in the dialysis industry, focusing on delivering high-quality patient care and innovative treatment solutions. Specialising in dialysis services, Diaverum offers a range of core products, including haemodialysis and peritoneal dialysis, tailored to meet the unique needs of patients. Their commitment to patient-centric care and advanced technology sets them apart in the market. With a strong emphasis on improving patient outcomes, Diaverum has achieved notable milestones, including expanding its network of clinics and enhancing service delivery. Recognised for its excellence in renal care, Diaverum continues to strengthen its position as a trusted partner in the healthcare sector, dedicated to transforming the lives of patients with chronic kidney disease.
How does Diaverum's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Diaverum's score of 26 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Diaverum reported total carbon emissions of approximately 30,687,000 kg CO2e, with Scope 1 emissions at about 3,507,000 kg CO2e and Scope 2 emissions at approximately 27,180,000 kg CO2e (market-based). This represents a slight increase from 2023, where total emissions were about 30,308,000 kg CO2e, with Scope 1 at approximately 2,274,000 kg CO2e and Scope 2 at around 28,034,000 kg CO2e (market-based). Diaverum's emissions data is cascaded from its parent company, Diaverum Sweden AB, indicating a corporate family relationship. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) nor does it have documented climate pledges or reduction initiatives. In 2022, emissions data for the UK indicated a total of approximately 7,836,000 kg CO2e, with Scope 1 emissions at about 22,000 kg CO2e, Scope 2 at approximately 623,000 kg CO2e, and significant Scope 3 emissions of around 7,192,000 kg CO2e, primarily from waste generated in operations. Overall, while Diaverum has made strides in reporting its emissions, it currently lacks formal reduction targets and initiatives to address its carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | - | 0,000,000 | 0,000,000 |
| Scope 2 | 19,731,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Diaverum has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

